A clinical trial examining the efficacy of two devices to monitor and detect atrial fibrillation (AF), or an irregular heartbeat, in ischemic stroke patients -- one an implantable device that monitors over 12 months, the other an external device that monitors over a 30-day period -- found the implantable device is more than three times more effective in detecting AF.
from Top Health News -- ScienceDaily https://ift.tt/34D0bcj
Subscribe to:
Post Comments (Atom)
Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO
However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...
-
New research links walnut consumption as a contributing factor that could suppress growth and survival of breast cancers. from Top Health ...
-
Researchers report on chimpanzees in Guinea fishing and consuming freshwater crabs, something previously undiscovered. The article describes...
-
The IT major further said the Ebit margin for the current quarter is expected to be between 20.5-21 per cent from Home Page https://ift.tt...
No comments:
Post a Comment